Strong signal in turbulent times: Vetter is CO2-neutral

- Energy-efficient and environmentally friendly technology in focus
- Use of green electricity at all German locations
- Savings of over 4,500 tons of carbon dioxide since 2014

While climate protection has recently gained renewed public attention, especially through the Fridays for Future movement last year, Vetter, a globally leading Contract Development and Manufacturing Organization (CDMO), has been addressing this topic on its corporate agenda for years. This year, the pharmaceutical service provider reached another milestone: Vetter makes its German sites CO2-neutral. This step marks an important building block in the environmental focus. It was made possible through a long-term sustainability strategy with corresponding measures. The company continuously invests in energy-efficient and environmentally friendly technology: for example, the pharmaceutical service provider relies on in-house combined heat and power plants, photovoltaic systems, and geothermal energy. As a result, over 4,500 tons of carbon dioxide have been saved since then. Additionally, since 2014, all German sites have been powered with green electricity from hydropower. Vetter offsets unavoidable residual emissions by supporting climate protection projects through the purchase of CO2 certificates.

"As a sustainable family business, we have taken our responsibility for the environment and climate protection very seriously for years. Whenever possible, we implement the most environmentally friendly solution," says Managing Director Thomas Otto. In the pharmaceutical sector, high standards and numerous regulatory requirements apply. Henryk Badack, Senior Vice President of Technical Service / Internal Project Management, explains: "In our industry, high standards for ensuring aseptic production conditions are rightly in place, ultimately to provide patients worldwide with flawless medications. Therefore, we cannot completely avoid residual emissions everywhere. That makes it all the more important for us to offset them meaningfully." CO2 compensation is one way to do this, meaning that greenhouse gas emissions are offset elsewhere through the financing of climate protection measures.

"We continue to work on keeping our company's ecological footprint as small as possible," says Managing Director Peter Sölkner. "As a long-term oriented family business, we see this as an important part of our social responsibility, also towards our children and grandchildren." In addition to reducing greenhouse gases, environmentally friendly collaborations are also in focus: the company involves its suppliers in environmental protection efforts to promote the use of energy-efficient technologies. Beyond its core business, the pharmaceutical service provider makes an important contribution to a better quality of life through these sustainability measures.